| (CAD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -10.82M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CRDL.TO returned +59.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +96.9% |
| 1 year | +59.3% |
| 5 years | -44.9% |
| All-time high | $7.74 (Feb 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CRDL.TO would be worth today ›No. Cardiol Therapeutics Inc. has not paid a dividend in the past 12 months.
Cardiol Therapeutics Inc. is part of the Healthcare sector.
Cardiol Therapeutics Inc. has a market cap of 301.40M CAD, based on the latest quote.
Cardiol Therapeutics Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
